The Advisory Panel on Substance Misuse (APoSM) was invited to review the Welsh Government policy response to the increase in drug-related deaths related to tramadol and other…
The Science and Technology Committee examined the opportunities and risks of ‘big data’ in 2015. The Society responded to the inquiry in September 2015. The Committee recently…
The Society welcomes the additions to the NHS Constitution regarding patient data that make clear patients’ legal rights. Changes to the NHS Constitution represent an important step…
The UK Concordat to Support the Career Development of Researchers is an agreement between funders and employers of research staff to improve the employment and support for researchers…
The European Medicines Agency (EMA) ran a consultation to discuss their proposed policy for access to clinical trial data for data submitted to the EMA from January 2014. BPS noted…
The Society responded to the Ethical Standards in the Health & Life Sciences Group’s (ESHLSG) consultation to highlight our support for declaration of payments made to healthcare…
The Society provided a written response to the consultation on the expansion of undergraduate medical education. The consultation was based on the government proposals to increase the…
The GMC is planning to introduce a process of credentialing in 2019 that will recognise expertise and provide training opportunities in areas of practice where there may be…
The Home Office consulted on the views of the Advisory Council on the Misuse of Drugs’ (ACMD) recommendation to reschedule ketamine to Schedule 2 of the Misuse of Drugs…
The Home Office ran a consultation on the scheduling of tramadol under the Misuse of Drugs Regulations 2001. This followed a Ministerial decision, in principle, to accept the ACMD's…
